Literature DB >> 12181231

Acute myocardial infarction: reperfusion treatment.

Flavio Ribichini1, William Wijns.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12181231      PMCID： PMC1767333          DOI： 10.1136/heart.88.3.298

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  20 in total

Review 1.  Cost-effectiveness of reperfusion strategies.

Authors:  W W Parmley
Journal:  Am Heart J       Date:  1999-08       Impact factor: 4.749

2.  Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2).

Authors:  A J Tiefenbrunn; N C Chandra; W J French; J M Gore; W J Rogers
Journal:  J Am Coll Cardiol       Date:  1998-05       Impact factor: 24.094

3.  Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto-1 study. The GISSI Investigators.

Authors:  M G Franzosi; E Santoro; C De Vita; E Geraci; A Lotto; A P Maggioni; F Mauri; F Rovelli; L Santoro; L Tavazzi; G Tognoni
Journal:  Circulation       Date:  1998-12-15       Impact factor: 29.690

4.  A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1997-06-05       Impact factor: 91.245

5.  Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators.

Authors:  E M Antman; R P Giugliano; C M Gibson; C H McCabe; P Coussement; N S Kleiman; A Vahanian; A A Adgey; I Menown; H J Rupprecht; R Van der Wieken; J Ducas; J Scherer; K Anderson; F Van de Werf; E Braunwald
Journal:  Circulation       Date:  1999-06-01       Impact factor: 29.690

6.  Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review.

Authors:  W D Weaver; R J Simes; A Betriu; C L Grines; F Zijlstra; E Garcia; L Grinfeld; R J Gibbons; E E Ribeiro; M A DeWood; F Ribichini
Journal:  JAMA       Date:  1997-12-17       Impact factor: 56.272

7.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

Authors:  J S Hochman; L A Sleeper; J G Webb; T A Sanborn; H D White; J D Talley; C E Buller; A K Jacobs; J N Slater; J Col; S M McKinlay; T H LeJemtel
Journal:  N Engl J Med       Date:  1999-08-26       Impact factor: 91.245

8.  Patterns of practice for acute myocardial infarction in a population from ten countries.

Authors:  F Venturini; M Romero; G Tognoni
Journal:  Eur J Clin Pharmacol       Date:  1999-01       Impact factor: 2.953

9.  Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators.

Authors:  S J Brener; L A Barr; J E Burchenal; S Katz; B S George; A A Jones; E D Cohen; P C Gainey; H J White; H B Cheek; J W Moses; D J Moliterno; M B Effron; E J Topol
Journal:  Circulation       Date:  1998-08-25       Impact factor: 29.690

10.  Coronary thrombosis during acute myocardial infarction: Roberts was right!

Authors:  W W O'Neill
Journal:  Am J Cardiol       Date:  1998-10-01       Impact factor: 2.778
View more
  12 in total

Review 1.  Interleukin-17 contributes to cardiovascular diseases.

Authors:  Hua-Sheng Ding; Jun Yang; Jian Yang; Jia-Wang Ding; Ping Chen; Ping Zhu
Journal:  Mol Biol Rep       Date:  2012-02-14       Impact factor: 2.316

2.  Sequential expression of TLR4 and its effects on the myocardium of rats with myocardial ischemia-reperfusion injury.

Authors:  Jun Yang; Jian Yang; Jia-wang Ding; Li-hua Chen; Yan-lin Wang; Song Li; Hui Wu
Journal:  Inflammation       Date:  2008-10       Impact factor: 4.092

3.  Valsartan preconditioning protects against myocardial ischemia-reperfusion injury through TLR4/NF-kappaB signaling pathway.

Authors:  Jian Yang; Hong Jiang; Jun Yang; Jia-Wang Ding; Li-Hua Chen; Song Li; Xiao-Dong Zhang
Journal:  Mol Cell Biochem       Date:  2009-04-16       Impact factor: 3.396

Review 4.  The roles of resveratrol on cardiac mitochondrial function in cardiac diseases.

Authors:  Apiwan Arinno; Nattayaporn Apaijai; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Eur J Nutr       Date:  2020-05-06       Impact factor: 5.614

Review 5.  Roles of melatonin and its receptors in cardiac ischemia-reperfusion injury.

Authors:  Kodchanan Singhanat; Nattayaporn Apaijai; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Cell Mol Life Sci       Date:  2018-08-13       Impact factor: 9.261

6.  Role of CC-chemokine receptor 5 on myocardial ischemia-reperfusion injury in rats.

Authors:  Bo Shen; Jun Li; Ling Gao; Jieyu Zhang; Bo Yang
Journal:  Mol Cell Biochem       Date:  2013-03-03       Impact factor: 3.396

7.  Integrative computational and experimental approaches to establish a post-myocardial infarction knowledge map.

Authors:  Nguyen T Nguyen; Xiaolin Zhang; Cathy Wu; Richard A Lange; Robert J Chilton; Merry L Lindsey; Yu-Fang Jin
Journal:  PLoS Comput Biol       Date:  2014-03-20       Impact factor: 4.475

8.  NecroX-5 protects mitochondrial oxidative phosphorylation capacity and preserves PGC1α expression levels during hypoxia/reoxygenation injury.

Authors:  Vu Thi Thu; Hyoung Kyu Kim; Le Thanh Long; Bayalagmaa Nyamaa; In-Sung Song; To Thanh Thuy; Nguyen Quang Huy; Jubert Marquez; Soon Ha Kim; Nari Kim; Kyung Soo Ko; Byoung Doo Rhee; Jin Han
Journal:  Korean J Physiol Pharmacol       Date:  2016-02-23       Impact factor: 2.016

9.  Public Awareness of Sepsis Compared to Acute Myocardial Infarction and Stroke in Jeddah, Saudi Arabia: Questionnaire Study.

Authors:  Nourah Al-Orainan; Adel Mohamed El-Shabasy; Khawlah Alamin Al-Shanqiti; Rawan Awad Al-Harbi; Hadeel Rajeh Alnashri; Raghad Ahmed Rezqallah; Alanoud Abdallah Mirghani
Journal:  Interact J Med Res       Date:  2020-06-15

10.  The Effect of Intracoronary Infusion of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells on Remodeling of Post-Infarcted Heart in Patient with Acute Myocardial Infarction.

Authors:  Małgorzata Peregud-Pogorzelska; Krzysztof Przybycień; Bartłomiej Baumert; Maciej Kotowski; Ewa Pius-Sadowska; Krzysztof Safranow; Jarosław Peregud-Pogorzelski; Zdzisława Kornacewicz-Jach; Edyta Paczkowska; Bogusław Machaliński
Journal:  Int J Med Sci       Date:  2020-04-06       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.